CClinicalTrials.gg
CompletedNCT01907022RELAXUpdated Mar 12, 2015

Combined rTMS and Relaxation in Chronic Tinnitus

An interventional study of Left DLPFC Butterfly Coil in Chronic Tinnitus, sponsored by University of Regensburg. Completed at 1 site in Germany. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2015-03-12.

Sponsored by University of Regensburg · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Repetitive Transcranial Magnetic Stimulation in combination with relaxation therapy is used to modulate the neural pathways contributing to the perception and distress of phantom sounds.

Read the detailed description

Tinnitus is the phantom auditory perception of sound in the absence of an external or internal acoustic stimulus. It is a frequent problem which can interfere significantly with the ability to lead a normal life. One significant modulator of tinnitus is stress. Tinnitus has been shown to be generated in the brain, as a result of functional reorganization of auditory neural pathways and the central auditory system. Also non-auditory cortical areas of attention allocation and emotional processing was shown to be involved. Treatment remains difficult. The most effective treatment in chronic tinnitus is cognitive behavioral therapy including elements of relaxation therapy. Repetitive transcranial magnetic stimulation (rTMS) is also effective in treatment of tinnitus with moderate effect size. Pilot data were positive for low-frequency rTMS applied to the temporoparietal areas and high-frequency rTMS applied to the left frontal cortex. Newer findings indicate that exercise-combined non-invasive brain stimulation might show superior effects in contrast to rTMS or exercise alone. Combination of relaxation and two-sided (frontal and temporo-parietal) rTMS will be examined with regard to feasibility, safety and clinical efficacy in patients suffering from chronic tinnitus in a pilot trial.

02

Conditions studied

  • Chronic Tinnitus

Browse trials for

Keywords

  • repetitive transcranial magnetic stimulation
  • chronic tinnitus
  • relaxation
03

In context

Tinnitus

412 studies on the registry are indexed under Tinnitus; 87 are open to participants now.

This study's enrollment of 42 is below the median of 60 across 339 interventional studies indexed under Tinnitus.

Browse Tinnitus studies →

Lead sponsor

University of Regensburg is the lead sponsor of 67 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosis of bothersome, subjective chronic tinnitus
  • Duration of tinnitus more than 6 months

Exclusion criteria

Exclusion Criteria:

  • Objective tinnitus
  • Treatable cause of the tinnitus
  • Involvement in other treatments for tinnitus at the same time
  • Clinically relevant psychiatric comorbidity
  • Clinically relevant unstable internal or neurological comorbidity
  • History of or evidence of significant brain malformation or neoplasm, head injury
  • Cerebral vascular events
  • Neurodegenerative disorder affecting the brain or prior brain surgery
  • Metal objects in and around body that can not be removed
  • Pregnancy
  • Alcohol or drug abuse
  • Prior treatment with TMS
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
42 participants (actual)

Study arms

  • Experimental
    Left dorsolateral prefrontal cortex (DLPFC) Butterfly Coil

    High frequency rTMS ( Alpine Biomed Mag Pro Option): 2000 stimuli of 20 Hz over the left DLPFC (each session), Butterfly-water-cooled-Coil, 110% motor threshold; followed by: low frequency rTMS ( Alpine Biomed Mag Pro Option) applied over left temporoparietal cortex, Butterfly-water-cooled-Coil (2000 Stimuli of 1 Hz each session), 110% motor threshold. Relaxation therapy during the 1Hz stimulation with external audio tape instructions.

    Device: Left DLPFC Butterfly Coil

Interventions

  • DeviceLeft DLPFC Butterfly Coil

    High frequency rTMS ( Alpine Biomed Mag Pro Option): 2000 stimuli of 20 Hz over the left DLPFC (each session), Butterfly-water-cooled-Coil, 110% motor threshold; followed by: low frequency rTMS ( Alpine Biomed Mag Pro Option) applied over left temporoparietal cortex, Butterfly-water-cooled-Coil (2000 Stimuli of 1 Hz each session), 110% motor threshold. Relaxation therapy during the 1Hz stimulation with external audio tape instructions. Arms: Left DLPFC Butterfly Coil

06

What researchers measure

Primary outcomes

  1. Number of treatment responders (TQ reduction > 5, contrast Baseline versus end of treatment)

    Time frame: Week 12

Secondary outcomes

  1. Change of tinnitus severity as measured by the Tinnitus Questionaire of Goebel&Hiller

    Time frame: Week 4

  2. Change of tinnitus severity as measured by the Tinnitus Handicap Inventory (THI)

    Time frame: Week 4

  3. Change of tinnitus severity as measured by the Tinnitus Severity Scale

    Time frame: Week 4

  4. Change of tinnitus severity as measured by the Tinnitus Questionaire of Goebel&Hiller

    Time frame: Week 2

  5. Change of tinnitus severity as measured by the Tinnitus Handicap Inventory (THI)

    Time frame: Week 2

  6. Change of tinnitus severity as measured by the Tinnitus Severity Scale

    Time frame: Week 2

  7. Change of depressive symptoms as measured by the Major Depression Inventory (MDI)

    Time frame: Week 4

  8. Change of depressive symptoms as measured by the Major Depression Inventory (MDI)

    Time frame: Week 2

  9. Change in quality of life as measured by the World Health Organization Quality of Life (WHOQoL)

    Time frame: Week 2

  10. Change in quality of life as measured by the World Health Organization Quality of Life(WHOQoL)

    Time frame: Week 4

  11. Change of tinnitus severity as measured by the Tinnitus Questionaire of Goebel&Hiller

    Time frame: Week 12

  12. Change of tinnitus severity as measured by the Tinnitus Handicap Inventory (THI)

    Time frame: Week 12

  13. Change of tinnitus severity as measured by the Tinnitus Severity Scale

    Time frame: Week 12

  14. Change in quality of life as measured by the World Health Organization Quality of Life (WHOQoL)

    Time frame: Week 12

07

Study locations

1 site
  • University of Regensburg - Dept of Psychiatry
    Regensburg, 93053, Germany
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 12, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01907022
Lead sponsor
University of Regensburg
Responsible party
Berthold Langguth, MD, Ph.D. (MD, PhD, University of Regensburg) — Principal investigator
First posted
Jul 24, 2013
Start date
Jul 2013
Primary completion
Jul 2014
Completion
Oct 2014
Last update
Mar 12, 2015

Study contacts

Berthold Langguth, MD, Ph.D.
principal investigator · University of Regensburg - Dept of Psychiatry

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion